Eyebright Medical Technology (Beijing) Co., Ltd. (SHA:688050)

Market Cap	8.20B -45.4%
Revenue (ttm)	1.52B +4.6%
Net Income	264.89M -29.9%
EPS	1.37 -31.3%
Shares Out	193.40M
PE Ratio	30.85
Forward PE	18.85
Dividend	0.32 (0.74%)
Ex-Dividend Date	Jul 18, 2025

Volume	2,434,201
Open	43.12
Previous Close	43.10
Day's Range	41.83 - 43.20
52-Week Range	41.92 - 83.83
Beta	0.48
Analysts	Buy
Price Target	71.66 (+69.09%)
Earnings Date	Aug 21, 2026

About SHA:688050

Eyebright Medical Technology (Beijing) Co., Ltd. engages in development, production, and commercialization of ophthalmic medical devices in China and internationally. The company offers intraocular, trimmers, capsular tension ring, defocus lense, orthokeratology, and contact lenses in the areas of surgical treatment, myopia management, and consumer vision care. It also provides solutions for ophthalmic surgery, refractive error correction, and optometry consumption. Eyebright Medical Technology (Beijing) Co., Ltd. was founded in 2010 and is hea...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 2,331
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688050

Financial Performance

In 2025, SHA:688050's revenue was 1.48 billion, an increase of 5.15% compared to the previous year's 1.41 billion. Earnings were 268.17 million, a decrease of -30.96%.